3-iodothyronamine differentially modulates -2A-adrenergic receptor-mediated signaling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
3-iodothyronamine differentially modulates -2A-adrenergic receptor-mediated signaling
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 54, Issue 3, Pages 205-216
Publisher
Bioscientifica
Online
2015-04-16
DOI
10.1530/jme-15-0003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The G Protein-coupled Receptor P2Y14Influences Insulin Release and Smooth Muscle Function in Mice
- (2014) Jaroslawna Meister et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotype-based treatment of type 2 diabetes with an 2A-adrenergic receptor antagonist
- (2014) Y. Tang et al. Science Translational Medicine
- Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2
- (2013) Carolin L Piechowski et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T1AM treatment
- (2013) J.A. Haviland et al. Obesity
- 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice
- (2012) Maria Elena Manni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines
- (2012) Décio L. Eizirik et al. PLoS Genetics
- Identification of novel transcripts in annotated genomes using RNA-Seq
- (2011) A. Roberts et al. BIOINFORMATICS
- Thyronamines—Past, Present, and Future
- (2011) S. Piehl et al. ENDOCRINE REVIEWS
- Mutually Opposite Signal Modulation by Hypothalamic Heterodimerization of Ghrelin and Melanocortin-3 Receptors
- (2011) Anne Rediger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence for Extrathyroidal Formation of 3-Iodothyronamine in Humans as Provided by a Novel Monoclonal Antibody-Based Chemiluminescent Serum Immunoassay
- (2011) Carolin S. Hoefig et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Detection of 3-Iodothyronamine in Human Patients: A Preliminary Study
- (2011) Elena Galli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists
- (2011) Gunnar Kleinau et al. PLoS One
- Exploring a role for heteromerization in GPCR signalling specificity
- (2010) Raphael Rozenfeld et al. BIOCHEMICAL JOURNAL
- Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine
- (2010) Alessandro Saba et al. ENDOCRINOLOGY
- GPCR Dimers Fall Apart
- (2010) N. A. Lambert Science Signaling
- Interference of a Mutant Thyroid Hormone Receptor α1 with Hepatic Glucose Metabolism
- (2009) Milica Vujovic et al. ENDOCRINOLOGY
- Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes
- (2009) A. H. Rosengren et al. SCIENCE
- The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents
- (2008) W. S. Dhillo et al. DIABETES OBESITY & METABOLISM
- 3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team?
- (2008) Thomas S. Scanlan ENDOCRINOLOGY
- Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling
- (2008) Jean-Pierre Vilardaga et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started